Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Inflammatory Bowel Diseases

Free Subscription 23.02.2026 1 Aliment Pharmacol Ther 1 Am J Gastroenterol 3 Clin Gastroenterol Hepatol 2 Dig Dis 6 Dig Dis Sci 1 Gut 6 Inflamm Bowel Dis 2 J Clin Gastroenterol 7 J Crohns Colitis 1 Mediators Inflamm 1 Proc Natl Acad Sci U S A 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. MEDAWAR E, Chaudhary H, Zoughlami A, Ekhdoura M, et al
   Systematic Review of Published Guidelines: Recommendations for Exams Under Anaesthesia, Seton Insertion and Timing of Seton Removal for Perianal and Rectovaginal Fistulising Crohn's Disease.
   Aliment Pharmacol Ther. 2026 Feb 16. doi: 10.1111/apt.70569.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

2. SCALDAFERRI F, Di Vincenzo F, Aloi M, Ascolani M, et al
   Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.
   Am J Gastroenterol. 2026 Feb 18. doi: 10.14309/ajg.0000000000003969.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

3. AXELRAD J, Faye AS, Soderling J, Marild K, et al
   Incidence and risk of colorectal dysplasia in patients with inflammatory bowel disease: A nationwide cohort study.
   Clin Gastroenterol Hepatol. 2026 Feb 16:S1542-3565(26)00097.
   PubMed         Abstract available
   
   
4. LEMSER CE, Koziol A, Boelt SG, MacSween N, et al
   Pre-diagnostic Changes in the Metabolome of Inflammatory Bowel Disease.
   Clin Gastroenterol Hepatol. 2026 Feb 17:S1542-3565(26)00137.
   PubMed         Abstract available
   
   
5. YERUSHALMY-FELER A, Spencer EA, Dubinsky MC, Suskind DL, et al
   Upadacitinib Maintenance Therapy in Pediatric Ulcerative Colitis: 52-week Multicenter Study from the Porto Group of ESPGHAN.
   Clin Gastroenterol Hepatol. 2026 Feb 17:S1542-3565(26)00138.
   PubMed         Abstract available
   
   

   
   Dig Dis

6. REN K, Cong Y, Jin Y, Zhou T, et al
   Inflammatory bowel disease burden in Six Different Dietary Regions and Worldwide.
   Dig Dis. 2026 Feb 20:1-37. doi: 10.1159/000550714.
   PubMed         Abstract available
   
   
7. JUD N, Biedermann L, Kreienbuehl AS, Pagkalidou E, et al
   Clinical Utility of Intestinal Ultrasound for Guiding Therapy in Inflammatory Bowel Disease: A Retrospective Real-World Cohort from a Swiss Tertiary Center.
   Dig Dis. 2026;44:42-49.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

8. JI Y, Li P, Liu Y, Shen D, et al
   Persistent Gene Activation as a Molecular Signature of Ulcerative Colitis Progression to Colorectal Cancer.
   Dig Dis Sci. 2026 Feb 20. doi: 10.1007/s10620-026-09742.
   PubMed         Abstract available
   
   
9. SHLOMO Y, Lital B, Ofra C, Yehudit C, et al
   Effect of Perianal Disease on Quality of Life, Fecal Incontinence, and Sexual Function in Patients with Crohn's Disease.
   Dig Dis Sci. 2026 Feb 16. doi: 10.1007/s10620-026-09766.
   PubMed         Abstract available
   
   
10. ODAH T, Deceus F, Tamim H, Farraye FA, et al
    Crohn's Disease-Related Abdominal and Pelvic Abscesses: Treatment Patterns and Outcomes.
    Dig Dis Sci. 2026 Feb 19. doi: 10.1007/s10620-026-09751.
    PubMed         Abstract available
    
    
11. WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
    Impact of Comorbid Psoriasis on the Efficacy of Ustekinumab and Mirikizumab in Inflammatory Bowel Disease: A Post-hoc Analysis of UNITI, SEAVUE, and LUCENT.
    Dig Dis Sci. 2026 Feb 19. doi: 10.1007/s10620-026-09752.
    PubMed         Abstract available
    
    
12. KELLERMAYER R, Szigeti RG, Sammer M, Vogel AM, et al
    Type 1 Dolichocolon as a Potential Anatomic Co-morbidity in Children with Perianal Crohn's Disease.
    Dig Dis Sci. 2026 Feb 18. doi: 10.1007/s10620-026-09759.
    PubMed         Abstract available
    
    
13. AHUJA D, Choi J, Zou G, Goodwin SW, et al
    Impact of Age on Efficacy and Safety of Advanced Therapies During Induction in Ulcerative Colitis: An Individual Patient Data Pooled Analysis from Randomized Controlled Trials.
    Dig Dis Sci. 2026 Feb 16. doi: 10.1007/s10620-026-09753.
    PubMed         Abstract available
    
    

    
    Gut

14. 
    Correction: Patient-derived organoid biobank identifies epigenetic dysregulation of intestinal epithelial MHC-I as a novel mechanism in severe Crohn's Disease.
    Gut. 2026 Feb 18:gutjnl-2024-332043corr1. doi: 10.1136/gutjnl-2024-332043.
    PubMed        
    
    

    
    Inflamm Bowel Dis

15. WANCHAITANAWONG W, Lohsiriwat V, Srisajjakul S, Salaemae M, et al
    Clinical characteristics of isolated perianal Crohn's disease and validation of the TOpClass criteria: a retrospective cohort pilot study.
    Inflamm Bowel Dis. 2026 Feb 20:izag028. doi: 10.1093.
    PubMed         Abstract available
    
    
16. LIU X, Gao JB, Li WX, Xu CY, et al
    Electroacupuncture at Baliao Points Alleviates Ulcerative Colitis via alpha7nAChR-Mediated Macrophage Polarization and Gut Microbiota Modulation.
    Inflamm Bowel Dis. 2026 Feb 17:izaf321. doi: 10.1093.
    PubMed         Abstract available
    
    
17. GUPTA A, Ungaro RC, Steinlauf A, Colombel JF, et al
    Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study.
    Inflamm Bowel Dis. 2026 Feb 18:izag021. doi: 10.1093.
    PubMed         Abstract available
    
    
18. CLUA L, Suau R, Guasch M, Monfort-Ferre D, et al
    Characterization of mesocolic adipose hyperplasia in a rat 2,4,6-trinitrobenzenesulfonic acid colitis model and comparison to creeping fat in Crohn disease.
    Inflamm Bowel Dis. 2026 Feb 18:izaf328. doi: 10.1093.
    PubMed         Abstract available
    
    
19. NOVIELLO D, Caprioli F
    The long game in ulcerative colitis: mirikizumab's four-year outcomes.
    Inflamm Bowel Dis. 2026 Feb 19:izag020. doi: 10.1093.
    PubMed        
    
    
20. ZHANG C, Li Y
    Reply: "A methodological concern regarding small-sample propensity score matching and overfitting in the study of postoperative biologic strategies for Crohn's disease".
    Inflamm Bowel Dis. 2026 Feb 19:izag025. doi: 10.1093.
    PubMed        
    
    

    
    J Clin Gastroenterol

21. FIERENS L, Liefferinckx C, Sabino J, De Dycker E, et al
    Development of an Evidence-based Quality Indicator Set for Patients With Inflammatory Bowel Disease in Belgium.
    J Clin Gastroenterol. 2026 Feb 23. doi: 10.1097/MCG.0000000000002145.
    PubMed         Abstract available
    
    
22. HOLMGREN J, Akhlaghi A, Drake I, Grip O, et al
    Risk of Infection Before and After Thiopurine Therapy in Inflammatory Bowel Disease: A Population-Based Study.
    J Clin Gastroenterol. 2026 Feb 13. doi: 10.1097/MCG.0000000000002351.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

23. WILLIAMS S, Meran L, McCartney S, Harrow P, et al
    REACH: C-cause.
    J Crohns Colitis. 2026;20.
    PubMed         Abstract available
    
    
24. SAID H, Moulton CD, Hart A, Keefer L, et al
    Holistic care in inflammatory bowel disease: is it in REACH?
    J Crohns Colitis. 2026;20.
    PubMed         Abstract available
    
    
25. NARDONE OM, Gros B, Parigi TL, Farooq A, et al
    Attaining sustainability in inflammatory bowel disease.
    J Crohns Colitis. 2026;20.
    PubMed         Abstract available
    
    
26. THAKOR A, Yogakanthi S, Noor NM, Parkes M, et al
    Rapid diagnosis and treatment of inflammatory bowel diseases.
    J Crohns Colitis. 2026;20.
    PubMed         Abstract available
    
    
27. BURISCH J, Banerjee R, Watermeyer G
    Equitable access to inflammatory bowel disease care: challenges, strategies, and future directions.
    J Crohns Colitis. 2026;20.
    PubMed         Abstract available
    
    
28. ESTEVINHO MM, Shakweh E, Cho W, Rozenberg F, et al
    Tunnel vision: Rethinking local therapy for perianal fistulas in Crohn's disease.
    J Crohns Colitis. 2026 Feb 16:jjag008. doi: 10.1093.
    PubMed         Abstract available
    
    
29. MARK-CHRISTENSEN A, Ebert AC, Poulsen GJ, Laurberg S, et al
    Risk of adverse pregnancy and birth outcomes after open versus laparoscopic surgery for inflammatory bowel disease: a nationwide cohort study.
    J Crohns Colitis. 2026;20:jjaf234.
    PubMed         Abstract available
    
    

    
    Mediators Inflamm

30. DAI L, Qiu C
    Integrated Multiomics Elucidates Molecular Mechanisms of Bisphenol A in Exacerbating Crohn's Disease.
    Mediators Inflamm. 2026;2026:2903373.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

31. LIU F, Zhuang W, Yang Y, Zhao W, et al
    The Crohn's disease-related RNF123 prevents NLRP3 inflammasome assembly by catalyzing unanchored K63-linked ubiquitination on NEK7.
    Proc Natl Acad Sci U S A. 2026;123:e2518759123.
    PubMed         Abstract available
    
    

    
    Z Gastroenterol

32. ALEXANIDOU E, Horning A, de Laffolie J, Schmidt-Choudhury A, et al
    [Crohn's Disease Exclusion Diet (CDED) and partial enteral nutrition (PEN) for remission induction in children and adolescents with Crohn's Disease - Updated statement from the CEDATA and Nutrition/Dietetics/Nutritional Medicine Working Groups of the
    Z Gastroenterol. 2026;64:184-198.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum